Bellevue Life Sciences Ac...

NASDAQ: BLAC · Real-Time Price · USD
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM

Bellevue Life Sciences Acquisition Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-2.41M 403.78K -35.39K -3.31K
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
n/a 517.35K 31.15K 2.85K
Other Non-Cash Items
n/a -2.78M n/a n/a
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
n/a 1.55M 31.15K 2.85K
Operating Cash Flow
-2.19M -818.77K -4.24K -461
Capital Expenditures
n/a -4 n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
35.91M -33.83M n/a n/a
Investing Cash Flow
35.91M -33.83M n/a n/a
Debt Repayment
n/a -1.2M 800K 100K
Common Stock Repurchased
n/a -36M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-33.67M 7.77M -676.02K 10K
Financial Cash Flow
-33.67M 34.54M 123.98K -57.44K
Net Cash Flow
50.72K -109.08K 119.74K -57.9K
Free Cash Flow
-2.19M -818.77K -4.24K -461